Which company develops and produces Axitinib?
Axitinib is an oral targeted treatment drug for advanced renal cell carcinoma developed and produced by Pfizer Inc. (Pfizer Inc.). Pfizer is a leading global biopharmaceutical company headquartered in the United States. Founded in 1849, it has decades of R&D and pharmaceutical experience.
Axitinib belongs to a class of drugs called tyrosine kinase inhibitors (tyrosine kinase inhibitors, TKIs), which fight the development of renal cell carcinoma by inhibiting the process of tumor cell growth and angiogenesis. The development of this drug is based on an in-depth understanding of cancer biology and molecular signaling pathways, aiming to provide more precise and personalized treatments.

Pfizer has been committed to developing innovative drugs, including drugs for the treatment of cancer, cardiovascular diseases, immunology and other fields. The company has extensive research and development facilities around the world and works closely with the medical community to advance science and improve patients' quality of life.
The development and production of axitinib represents Pfizer's contribution to the field of cancer treatment and provides an effective treatment option for patients with renal cell carcinoma. This is also an example of Pfizer's continuous efforts to promote medical innovation and provide better treatment options for patients around the world.
Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)